L&G Global Health & Pharmaceuticals Index Trust I Inc

ISIN: GB00B0CNH270 | MEX: LGHPTI | CITI: L003

  • Buy 102.8 GBX

  • Sell 102.8 GBX

  • Price Change -0.48400%

Past Performance

  • 16th Oct 2019 to 16th Oct 202016.73%
  • 16th Oct 2020 to 16th Oct 202110.38%
  • 16th Oct 2021 to 16th Oct 202211.43%
  • 16th Oct 2022 to 16th Oct 20230.49%
  • 16th Oct 2023 to 16th Oct 202410.86%

Objectives and Approach

The objective of this fund is to provide growth by tracking the performance of those companies in the FTSE World Index which are engaged in Health, Pharmaceuticals and Biotechnology activities. The fund will invest almost entirely in company shares. The fund's investments will closely match those that make up the Index. The Index consists of company shares from around the world. The fund may use derivatives (contracts which have a value linked to the price of another asset) for the following purposes: •To help with efficient day to day management. •To reduce some of the risks of the market. If you hold accumulation units, income from investments held by the fund (dividends) will be reinvested into the value of your units. If you hold distribution units, income from investments held by the fund will be paid out to you (as a dividend). This fund may not be appropriate for investors who plan to withdraw their money within five years.

Key Information

Inception 1st Nov 2000
Historic Yield 1.1000%
Sector IA Healthcare
Fund Size £1274.811mn
Fund Type UNIT
Classification Income

Charges

Total Ongoing Charges 
Please note that whilst we endeavour to show all charges associated with specific funds, sometimes this is not possible due to the information not being made available by the fund provider. In such cases transaction or incidental cost information may be missing.
0.4439%
Initial Charge 0%
AMC 0.31%
Our Platform Charge
We charge a platform fee of 0.30%. Our charges are shown on our rates and charges sheet
0.30%

Cost and Charges Information

This calculator provides you with costs and charges information regarding our charges and, where relevant, the costs within this investment product

Account Type

  • Investment Account
  • Stocks & Shares ISA
  • SIPP

Annual charges

These are the annual costs based on an initial investment amount of over 1 year assuming a net zero growth rate

Cost Category % of Investment lump sum costs
Our annual fee

Our annual fee

Includes our platform fee at 0.30% per annum (excluding Charles Stanley Multi Asset Funds and anycash held). The min fee is £60, the max is £600 per annum, plus SIPP administration fee (if applicable, only charged if < £30,000 held) – see here
0.30%
Dealing charges

Dealing charges

Any one-off commission charges associated with investing. Note that government taxes and levies are not included. This does not include any commission credits you may have available
N/A
Product provider costs

Product provider costs

Product provider costs shown are inclusive of the fund ongoing charges figure (OCF), transaction costs and incidental costs
0.4439%
Total (£)

Total (£)

Costs per annum displayed in monetary value
Total (%)

Total (%)

Costs per annum displayed as a percentage of investment value

Cumulative effect of charges on your investment's return

This illustration assumes that costs occur evenly throughout the year, charges are paid out of the investment evenly throughout the year, and that an annual growth rate of applies evenly throughout the year, before any charges including product charges

lump sum invested with an assumed growth rate of 1 year years
What you might get back at  with no charges applied

What you might get back at  with no charges applied

These are the illustrative values of a  investment after growth and no costs applied at the end of the defined period
Annual charges

Annual charges

These are the annual costs based on an initial investment amount of assuming a net zero growth rate
Effect of charges on return (%)

Effect of charges on return (%)

These are the overall costs in percentage terms, based on an initial investment amount of assuming a growth rate
Effect of charges on return (£)

Effect of charges on return (£)

These are the overall costs in monetary value, based on an initial investment amount of assuming a growth rate
What you might get back at with charges applied

What you might get back at with charges applied

These are the illustrative values of a investment after growth and costs at the end of the defined period

This illustration is not a forecast of future investment performance but merely a means to demonstrate the potential impact of costs and charges for an assumed return of . Whilst we make reasonable endeavours to ensure the accuracy of third party charges information, this is intended for illustrative purposes only and should not be relied upon. We do not warrant or represent that this information is accurate, complete or up to date, therefore we accept no responsibility or liability for its use

Performance

  • Chart Options

    Select Timeframe
    From
    To
    Add comparator to chart
    None
    This fund's IA Sector (IA Healthcare)
    Another IA Sector
    Search for Fund Comparator
      Add a FTSE Index

      Current Comparators


      • Cumulative Performance

        1 month3 months6 months1 year3 years5 years
        -1.81% 2.09% 5.98% 10.86% 24.13% 59.94%

        Important Information
        Headline performance can mask the true characteristics of a fund. Without fully understanding how a fund is managed, you may inadvertently become exposed to an undesirable level of risk to your capital. Some funds carry a dilution levy which reduces the number of units realised on any initial investment as an initial charge. If this fund carries such a levy it should be detailed in the Key Investor Information Document (KIID), which we must provide and you should read before investing.

        The charts and performance data shown are supplied by an external data provider and may contain data that appears to precede the introduction of the clean unit class for this fund. In such cases, historical data has been synthesised at the entire discretion of that external provider as realistically as possible using historical data recorded against the previously available commission-paying version of the fund, adjusting for fees in the process.



      Composition

      Important Documents


      The documents listed below are the latest versions made available to our data provider by the fund management group, but may not necessarily reflect the applicable charges that would be levied should you purchase this fund via Charles Stanley Direct. You should treat the charges and other figures shown in the 'Overview' tab as accurate.

      Fund Provider Factsheet
      The Fact Sheet is supplied on a monthly basis by the management group and provides limited information on the fund. Past performance data and a review of how the fund has performed are commonly featured. &nbsp;
      FUND PROVIDER FACTSHEET
      700,507 bytes PDF Document; last updated 31 Aug 2024
      Key Investor Information Document This document, issued by the product provider, provides key information about an investment product. The information is required by law to help potential investors understand the nature, risks, costs, potential gains and losses of the product and enable comparison with other products.
      KEY INVESTOR INFORMATION DOCUMENT
      103,442 bytes PDF Document; last updated 02 May 2024
      Annual Report A report published by the Fund Management Group detailing the progress of the fund during the course of the previous 12 months. The information provided includes a financial statement for the group as a whole.
      ANNUAL REPORT
      466,434 bytes PDF Document; last updated 07 Jan 2024
      Semi Annual Report Published periodically through the course of the financial year of the fund, the report provides an overview of the fund's performance and the prospects for the remainder of the year. Included are portfolio changes (i.e. which stocks have been bought and sold), and changes in the geographical breakdown during the course of the previous 12 months.
      SEMI-ANNUAL REPORT
      290,000 bytes PDF Document; last updated 07 Jul 2024
      Prospectus This is a formal document which contains details of the funds' objectives, investment strategies, risks, performance, distribution policy, fees and expenses and, fund management style.  A fund’s prospectus must be lodged with the Financial Conduct Authority (FCA) for authorisation.
      PROSPECTUS
      1,316,530 bytes PDF Document; last updated 13 Aug 2024

      Management Team

      Index Fund Management Team has managed this fund for 11 years .

       Index Fund Management Team The Index Fund Management team comprises 25 fund managers, supported by two analysts. Management oversight is provided by the Global Head of Index Funds. The team has average industry experience of 15 years, of which seven years has been at LGIM, and is focused on achieving the equally important objectives of close tracking and maximising returns.

      Manager Cumulative Performance v Peer Group

      Performance Graph

      All funds managed by Index Fund Management Team

      Name of Security Sole/Co Managed Since
      L&G European Index Tst Sole Sep 2013
      L&G Gbl Hlth&PharmIsdx Trst Sole Sep 2013
      L&G Gbl Infln Lkd Bd Index Co Sep 2013
      L&G UK 100 Index Trust Co Sep 2013
      L&G All StcksIdxLkdGltIdx Tst Sole Feb 2014
      L&G Gbl Infln Lkd Bd Index Co Sep 2013
      L&G US Index Trust Sole Sep 2013
      L&G Em Gov Bd (US$) Index Co Sep 2013
      L&G International Index Tst Sole Sep 2013
      L&G Global 100 Index Trust Co Sep 2013
      L&G Em Gov Bd (US$) Index Co Sep 2013
      L&G All Stocks Gilt Index Tst Co Feb 2014
      L&G Japan Index Trust Sole Sep 2013
      L&G Global Equity Index Sole Sep 2014
      L&G Future World ESG UK Index Sole Apr 2019
      L&G Future World ESG UK Index Sole Apr 2019
      L&G MSCIWldSlyRsInstSRIIdx Co Sep 2013
      L&G European Index Tst Sole Sep 2013
      L&G Sterling Corporate Bd Idx Sole Sep 2013
      L&G All Stocks Gilt Index Tst Co Feb 2014
      L&G Japan Index Trust Sole Sep 2013
      L&G UK 350 Index Sole Sep 2013
      L&G US Index Trust Sole Sep 2013
      L&G All StcksIdxLkdGltIdx Tst Sole Feb 2014
      L&G UK 350 Index Sole Sep 2013
      L&G International Index Tst Sole Sep 2013
      L&G Sterling Corporate Bd Idx Sole Sep 2013
      L&G Future World ESG UK Index Sole Apr 2019
      L&G (N) Tracker Trust Sole Sep 2013
      L&G UK 100 Index Trust Co Sep 2013
      L&G UK 350 Index Sole Sep 2013
      L&G Gbl Technology Idx Trst Sole Feb 2014
      L&G FW ESG Dvlpd Idx Sole Apr 2019
      L&G Global Emerging Mkts Idx Co Sep 2013
      L&G FW ESG Dvlpd Idx Sole Apr 2019
      L&G MSCIWldSlyRsInstSRIIdx Co Sep 2013
      L&G Pacific Index Trust Sole Sep 2013
      L&G Pacific Index Trust Sole Sep 2013
      Ministry Of Justice EIdTr Sole Sep 2013
      L&G Global 100 Index Trust Co Sep 2013
      L&G (N) Tracker Trust Sole Sep 2013
      L&G Global Emerging Mkts Idx Co Sep 2013
      L&G UK Index Trust Co Sep 2013
      L&G Sht Dtd Stg Corp Bd Idx Sole Sep 2013
      L&G Global Equity Index Sole Sep 2014
      L&G Sht Dtd Stg Corp Bd Idx Sole Sep 2013
      L&G Future World ESG UK Index Sole Apr 2019
      L&G UK Index Trust Co Sep 2013

      Investment involves risk. You may get back less than invested.